跳至主要内容
临床试验/EUCTR2019-004007-12-GB
EUCTR2019-004007-12-GB进行中(未招募)1 期

Brain connectivity and patient reported outcomes in people with HIV (PWH) with symptoms of insomnia switching integrase inhibitor-based ART; a randomised controlled study - BIC CNS Study

niversity of Sussex0 个研究点目标入组 46 人开始时间: 2020年3月2日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - HIV-1 positive
  • - age = 18 years
  • - plasma HIV RNA < 50 copies/mL at screening and on at least one other occasion over the last 3 months
  • - acceptable medical history and laboratory parameters (haematology and chemistry) in the opinion of the investigator
  • - On a stable antiretroviral regimen comprising of Triumeq™ once daily for >4 months
  • - A total score of 8 or greater in the Insomnia Severity Index
  • - BMI 18 - 32, inclusive
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 40
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 6

排除标准

  • - Significant neurological disease
  • - Current history of major depression or psychosis
  • - Diagnosed sleep disorder (sleep apnoea, narcolepsy)
  • - Current medication which is likely to interfere with sleep
  • - Recent head injury (past 30 days)
  • - Current alcohol abuse or drug of abuse dependence
  • - Active opportunistic infection or significant co-morbidities
  • - Pregnancy

研究者

发起方
niversity of Sussex

相似试验